Given the documented effectiveness of GLUT-1 inhibitors in various cancer cells (lymphoma, prostate cancer, gastric cancer) [24] we examined the effect of our GLUT-1 inhibitors on mesothelioma cells. This evidence concerns the gene SLC2A1 and mesothelioma.